These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3701778)

  • 21. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor.
    Rognan D; Sokoloff P; Mann A; Martres MP; Schwartz JC; Costentin J; Wermuth CG
    Eur J Pharmacol; 1990 Jul; 189(1):59-70. PubMed ID: 1977603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
    Pettersson I; Gundertofte K; Palm J; Liljefors T
    J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists.
    Vasiliadis HM; Elie R; Dewar KM
    Eur J Pharmacol; 1999 Dec; 386(2-3):155-63. PubMed ID: 10618465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.
    Yakushev IY; Dupont E; Buchholz HG; Tillmanns J; Debus F; Cumming P; Heimann A; Fellgiebel A; Luhmann HJ; Landvogt C; Werhahn KJ; Schreckenberger M; Potschka H; Bartenstein P
    Epilepsia; 2010 Mar; 51(3):415-22. PubMed ID: 19694792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
    Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of halogen atoms for representing intermolecular electrostatic interactions related to halogen bonding and their substituent effects.
    Torii H; Yoshida M
    J Comput Chem; 2010 Jan; 31(1):107-16. PubMed ID: 19421995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain receptor autoradiography with [3H]-YM 09151-2: a ligand for labeling dopamine D-2 receptors.
    Unis AS; Vincent JG; Dillon B
    Life Sci; 1990; 47(25):PL151-5. PubMed ID: 2148202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
    Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular electrostatic potential of D1 and D2 dopamine agonists.
    Alkorta I; Villar HO
    J Med Chem; 1994 Jan; 37(1):210-3. PubMed ID: 7904647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
    Hadley MS; King FD; McRitchie B; Turner DH; Watts EA
    J Med Chem; 1985 Dec; 28(12):1843-7. PubMed ID: 4068007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of dopamine antagonists using functional feature hypothesis and topological descriptors.
    Kim HJ; Cho YS; Koh HY; Kong JY; No KT; Pae AN
    Bioorg Med Chem; 2006 Mar; 14(5):1454-61. PubMed ID: 16256354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors.
    Cox BA; Henningsen RA; Spanoyannis A; Neve RL; Neve KA
    J Neurochem; 1992 Aug; 59(2):627-35. PubMed ID: 1321233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.